Secure software supply chain solution provider Chainguard Inc. today expanded its Chainguard Repository product with malware ...

Nine Java Enhancement Proposals make the final cut as OpenJDK shifts from feature development to bug fixing ahead of a September release.

Apple today announced that the Passwords app can now automatically update weak and compromised passwords using Apple Intelligence and Safari to take action on a user's behalf. The feature builds on ...

Today Apple unveiled major AI upgrades coming in iOS 27 and its other forthcoming software updates. One such AI feature involves the Apple Passwords app. Passwords launched two years ago as a ...

Apps from Apple, Google and others can assist in making your online accounts more secure, even as new ways of logging in continue to take off. By J. D. Biersdorfer J.D. Biersdorfer writes about how to ...

The Password Generator is designed to create strong and random passwords using Java🔐. The working of the project is based on simple logic combined with randomness to ensure security. Each time the ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Max Eddy Max Eddy is a writer who has covered privacy and security — including ...

We wouldn't blame you for assuming that AI, being a computer, would be better at generating passwords than a human. After all, people use AI to do everything from writing their emails to generating a ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...